SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 3
|
records per page:
next >
| last >>
|
| pages: 1 2 3
|
presentations:
1 to
50 of
102
|
CROI Program Committee Chair Welcome to Wednesday
Diane V. Havlir
University of California San Francisco, San Francisco, CA, USA
The End of Oral? How Long-Acting Formulations Are Changing the Management of Infectious Diseases (ABSTRACT
39)
Charles W. Flexner
The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Joseph J. Eron
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Diagnostics 4.0: The Future of Diagnostics for HIV and Related Infections (ABSTRACT
40)
Nitika P. Pai
McGill University, Montreal, Canada
Jonathan Mermin
Centers for Disease Control and Prevention, Atlanta, GA, USA
High Rates of Viral Suppression in Pregnancy Drop Postpartum in South African Women on TLD (ABSTRACT
182)
Elaine J. Abrams
Columbia University, New York, NY, USA
Hypertension in a Randomized Trial of DTG vs EFV-Based ART in Pregnant and Postpartum Women (ABSTRACT
183)
Risa Hoffman
University of California Los Angeles, Los Angeles, CA, USA
ART-Free HIV-1 Remission in Very Early Treated Children: Results From IMPAACT P1115 (ABSTRACT
184)
Deborah Persaud
The Johns Hopkins University School of Medicine
GIVE MOVE: Randomized Trial on Genotype-Informed Management of Viremia in Children and Adolescents (ABSTRACT
185)
Jennifer A. Brown
University Hospital Basel, Basel, Switzerland
QUESTIONS AND ANSWERS (Part 1)
ODYSSEY 192-Week Follow-Up Evidences Superior Efficacy of DTG for Children on First/Second-Line ART (ABSTRACT
186)
Hilda A. Mujuru
University of Zimbabwe
Emerging Dolutegravir Resistance Among Children Being Investigated for Treatment Failure in Malawi (ABSTRACT
187)
George Bello
International Training and Education Center for Health
Long-Acting Cabotegravir Plus Rilpivirine In Adolescents With HIV: Week 24 IMPAACT 2017(MOCHA) Study (ABSTRACT
188)
Aditya Gaur
St Jude Children's Research Hospital, Memphis, TN, USA
SEARCH: Youth Intervention Impact on Symptoms of Depression in East African Youth Living With HIV (ABSTRACT
189)
James Ayieko
Kenya Medical Research Institute, Nairobi, Kenya
Role of Community-Level Factors in Declines in HIV Incidence and Prevalence Among Rakai Adolescents (ABSTRACT
190)
John S. Santelli
Columbia University Medical Center, New York, NY, USA
QUESTIONS AND ANSWERS (Part 2)
Selection of Epigenetically Privileged HIV-1 Proviruses During Treatment With Panobinostat and IFNα (ABSTRACT
173)
Marie Armani-Tourret
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
Role of Cytoskeleton and Adhesion in a Rare Subset of HIV-Infected Cells That Resist CTL (ABSTRACT
174)
Louise Leyre
Weill Cornell Medicine, New York, NY, USA
Sex-Specific Innate Immune Selection in Vertical HIV Transmission and cART-Free Aviraemia in Males (ABSTRACT
175)
Gabriela Z.L. Cromhout
University of KwaZulu-Natal
Sex-Based Differences in HIV-1 Reservoir Profile in Individuals With Long-Term ART Suppression (ABSTRACT
176)
Toong Seng Tan
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
QUESTIONS AND ANSWERS (Part 1)
AAV-Expressed HIV IgG Biologics Enable Durable ART-Free Viral Control in Infant Macaques (ABSTRACT
177)
Mauricio A. Martins
University of Florida, Gainesville, FL, USA
Broadly Neutralizing Antibody-Secreting T Cells and CAR-Ts Potently Suppress In Vivo HIV Infection (ABSTRACT
178)
Hang Su
Albert Einstein College of Medicine, Bronx, NY, USA
Autologous Neutralizing Antibodies Contribute to Virus Control in a Subset of PWH Treated With bNAbs (ABSTRACT
179)
Katharine J. Bar
University of Pennsylvania, Philadelphia, PA, USA
A T Cell-Targeting mRNA SIV Vaccine Extends Time to Rebound and Enhances Post-ART Viral Control (ABSTRACT
180)
Benjamin Varco-Merth
Oregon Health and Sciences University, Portland, OR, USA
IL-15/IL-15RA Cytokine Therapy Enhances Control of Viral Rebound in SIV-Infected Macaques (ABSTRACT
181)
Vijayakumar Velu
Emory University, Atlanta, GA, USA
QUESTIONS AND ANSWERS (Part 2)
Together Take Me Home: Launch of a National HIV Self-Test Distribution Program, March-December 2023 (ABSTRACT
200)
Kevin P. Delaney
Centers for Disease Control and Prevention, Atlanta, GA, USA
Incidence of Health Facility Switching and HIV Viral Rebound in Uganda: A Population-Based Study (ABSTRACT
201)
Joseph G. Rosen
The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Improving Posthospital Outcomes in People With HIV: A Multicenter Randomized Trial in Tanzania (ABSTRACT
203)
Serena Koenig
Harvard Medical School, Boston, MA, USA
Lakeside Combined HIV and Schistosomiasis Services in Malawian Fishermen: A Cluster Randomized Trial (ABSTRACT
202)
Augustine T. Choko
Liverpool School of Tropical Medicine, Liverpool, UK
QUESTIONS AND ANSWERS (Part 1)
What Are the Outcomes for Established Clients Enrolled in DSD During the First 3 Years on ART? (ABSTRACT
204)
Amy N. Huber
University of the Witwatersrand, Johannesburg, South Africa
Opt-Out HIV Testing in Emergency Departments Successfully Addresses Key Gaps in Testing (ABSTRACT
205)
Lisa Hamzah
St George's University Hospitals NHS Foundation Trust
Few Discordant HIV Ag/Ab and RNA Test Results Among Persons in a National Cohort of PrEP Users (ABSTRACT
206)
Weiming Zhu
Centers for Disease Control and Prevention, Atlanta, GA, USA
Missed Opportunities to Prevent Congenital Syphilis in Antenatal PrEP Services in South Africa (ABSTRACT
207)
Dvora L. Joseph Davey
University of California Los Angeles, Los Angeles, CA, USA
QUESTIONS AND ANSWERS (Part 2)
Investigation of HIV Transmission Associated With Receipt of Vampire Facials: New Mexico, 2018-2023 (ABSTRACT
191)
Anna M. Behar
Centers for Disease Control and Prevention, Atlanta, GA, USA
Trends in Black-White Disparities in HIV Diagnosis: 2017-2021, United States (ABSTRACT
192)
André Dailey
Centers for Disease Control and Prevention, Atlanta, GA, USA
Estimating Lifetime Risk of a Diagnosis of HIV Infection Among MSM: United States, 2017-2021 (ABSTRACT
193)
Sonia Singh
Centers for Disease Control and Prevention, Atlanta, GA, USA
Quantifying HIV-1 Transmission Between People Who Inject Drugs and Other Populations in Kenya (ABSTRACT
194)
Hanley Kingston
University of Washington, Seattle, WA, USA
QUESTIONS AND ANSWERS (Part 1)
Demographics Are Crucial to Interpret 95-95-95 Targets in African Populations With High ART Coverage (ABSTRACT
195)
Andrea Brizzi
Imperial College London, London, UK
High Prevalence of Advanced HIV Disease in Sub-Saharan Africa: An Analysis of 11 Household Surveys (ABSTRACT
196)
Dominik Stelzle
World Health Organization, Geneva, Switzerland
Low-Level Viremia Trends Among Persons With HIV: A 5-Country Analysis From 10 PHIA Surveys (ABSTRACT
197)
Jessica E. Justman
Columbia University Medical Center, New York, NY, USA
|
<< first | < prev
page:
of 3
|
records per page:
next >
| last >>
|
| pages: 1 2 3
|
presentations:
1 to
50 of
102
|
